New York State Common Retirement Fund
AMLX icon

New York State Common Retirement Fund’s Amylyx Pharmaceuticals AMLX Stock Holding History

New York State Common Retirement Fund’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$616K Buy
34,300
+12,400
+57% +$192K ﹤0.01% 1920
2026
Q1 		$304K Hold
21,900
– – ﹤0.01% 2080
2025
Q4 		$265K Hold
21,900
– – ﹤0.01% 2174
2025
Q3 		$298K Hold
21,900
– – ﹤0.01% 2124
2025
Q2 		$140K Buy
+21,900
New +$107K ﹤0.01% 2404
2024
Q3 		– Sell
-444
Closed -$844 – 3185
2024
Q2 		$844 Sell
444
-20,800
-98% -$40.3K ﹤0.01% 3293
2024
Q1 		$60.3K Sell
21,244
-2,510
-11% -$32.8K ﹤0.01% 2926
2023
Q4 		$350K Buy
23,754
+2,519
+12% +$38.6K ﹤0.01% 2234
2023
Q3 		$389K Sell
21,235
-2,100
-9% -$44.4K ﹤0.01% 2154
2023
Q2 		$503K Sell
23,335
-3,396
-13% -$91.7K ﹤0.01% 2082
2023
Q1 		$784K Sell
26,731
-6,972
-21% -$242K ﹤0.01% 1950
2022
Q4 		$1.25M Buy
33,703
+10,297
+44% +$365K ﹤0.01% 1858
2022
Q3 		$659K Buy
23,406
+14,209
+154% +$354K ﹤0.01% 2190
2022
Q2 		$177K Buy
9,197
+5,197
+130% +$61.7K ﹤0.01% 2844
2022
Q1 		$51K Buy
+4,000
New +$90.3K ﹤0.01% 3166

Other funds holding AMLX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund's AMLX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Amylyx Pharmaceuticals (AMLX) stake by 57% in Q2 2026, buying an estimated $192K and bringing the position to 34,300 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

New York State Common Retirement Fund first reported a position in AMLX in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.25M in Q4 2022. 34 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • New York State Common Retirement Fund held 34,300 shares of Amylyx Pharmaceuticals worth $616K as of Q2 2026.
  • New York State Common Retirement Fund bought 12,400 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $192K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1920 holding.
  • New York State Common Retirement Fund first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
  • New York State Common Retirement Fund's Amylyx Pharmaceuticals position peaked at $1.25M in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.